Armata Pharmaceuticals (ARMP) Enterprise Value (2013 - 2026)

Armata Pharmaceuticals has disclosed Enterprise Value across 14 years of filings, most recently posting $216.7 million for Q2 2026.

• In Q2 2026, Enterprise Value rose 236.29% year-over-year to $216.7 million; the TTM figure through Jun 2026 stood at $216.7 million (up 236.29% YoY), while the FY2025 annual figure was $220.1 million, up 281.8% from the prior year.
• Enterprise Value came in at $216.7 million for Q2 2026 at Armata Pharmaceuticals, down from $370.4 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $370.4 million in Q1 2026 to a low of $28.7 million in Q2 2023.
• Average Enterprise Value over 5 years is $107.1 million, with a median of $89.4 million recorded in 2023.
• Year-over-year, Enterprise Value slumped 78.33% in 2022 and soared 800.12% in 2026.
• Over 5 years, Enterprise Value stood at $30.0 million in 2022, then surged by 245.43% to $103.5 million in 2023, then plunged by 44.31% to $57.6 million in 2024, then jumped by 281.8% to $220.1 million in 2025, then decreased by 1.54% to $216.7 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $216.7 million in Q2 2026, $370.4 million in Q1 2026, and $220.1 million in Q4 2025.